ESPR

#2200
Esperion Therapeutics, Inc. - Common Stock
3.1 3 USD
-0.32%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
3.13
3.13
Year Range
0.81
4.18
Daily Change
-0.32%
Monthly Change
+63.87%
6 month change
-20.56%
Year Change
+259.77%
Previous Close
3.1 4
Open
3.1 3
Low
3.1 3
High
3.1 3
Volume
69
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
Income statement Balance sheet Cash flow
Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM

Esperion Therapeutics, Inc. - Common Stock

Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.

News